Search for: All records

We report label-free, in vivo virtual histology of skin using reflectance confocal microscopy (RCM). We trained a deep neural network to transform in vivo RCM images of unstained skin into virtually stained H&E-like microscopic images with nuclear contrast. This framework successfully generalized to diverse skin conditions, e.g., normal skin, basal cell carcinoma, and melanocytic nevi, as well as distinct skin layers, including the epidermis, dermal-epidermal junction, and superficial dermis layers. This label-free in vivo skin virtual histology framework can be transformative for faster and more accurate diagnosis of malignant skin neoplasms, with the potential to significantly reduce unnecessary skin biopsies. 

We present a method to generate multiple virtual stains on an image of label-free tissue using a single deep neural network, which is fed with the autofluorescence images of the unlabeled tissue alongside a user-defined digital-staining matrix. Users can indicate which stain to apply on each pixel by editing the digital-staining matrix and blend multiple virtual stains, creating entirely new stain combinations. 

We present a deep learning-based technique to computationally transform H&E-stained tissue sections into different special stains. We also demonstrate that this stain-to-stain transformation framework improves diagnostic accuracy over the use of H&E only. 

Reflectance confocal microscopy (RCM) can provide in vivo images of the skin with cellular-level resolution; however, RCM images are grayscale, lack nuclear features and have a low correlation with histology. We present a deep learning-based virtual staining method to perform non-invasive virtual histology of the skin based on in vivo, label-free RCM images. This virtual histology framework revealed successful inference for various skin conditions, such as basal cell carcinoma, also covering distinct skin layers, including epidermis and dermal-epidermal junction. This method can pave the way for faster and more accurate diagnosis of malignant skin neoplasms while reducing unnecessary biopsies. 

Abstract Imaging through diffusers presents a challenging problem with various digital image reconstruction solutions demonstrated to date using computers. Here, we present a computer-free, all-optical image reconstruction method to see through random diffusers at the speed of light. Using deep learning, a set of transmissive diffractive surfaces are trained to all-optically reconstruct images of arbitrary objects that are completely covered by unknown, random phase diffusers. After the training stage, which is a one-time effort, the resulting diffractive surfaces are fabricated and form a passive optical network that is physically positioned between the unknown object and the image plane to all-optically reconstruct the object pattern through an unknown, new phase diffuser. We experimentally demonstrated this concept using coherent THz illumination and all-optically reconstructed objects distorted by unknown, random diffusers, never used during training. Unlike digital methods, all-optical diffractive reconstructions do not require power except for the illumination light. This diffractive solution to see through diffusers can be extended to other wavelengths, and might fuel various applications in biomedical imaging, astronomy, atmospheric sciences, oceanography, security, robotics, autonomous vehicles, among many others. 

We reportin vivovirtual histology of skin without a biopsy, where deep learning is used to virtually stain tissue and generate hematoxylin and eosin (H&E)-like microscopic images of skin using a reflectance confocal microscope. 

The immunohistochemical (IHC) staining of the human epidermal growth factor receptor 2 (HER2) biomarker is widely practiced in breast tissue analysis, preclinical studies, and diagnostic decisions, guiding cancer treatment and investigation of pathogenesis. HER2 staining demands laborious tissue treatment and chemical processing performed by a histotechnologist, which typically takes one day to prepare in a laboratory, increasing analysis time and associated costs. Here, we describe a deep learning-based virtual HER2 IHC staining method using a conditional generative adversarial network that is trained to rapidly transform autofluorescence microscopic images of unlabeled/label-free breast tissue sections into bright-field equivalent microscopic images, matching the standard HER2 IHC staining that is chemically performed on the same tissue sections. The efficacy of this virtual HER2 staining framework was demonstrated by quantitative analysis, in which three board-certified breast pathologists blindly graded the HER2 scores of virtually stained and immunohistochemically stained HER2 whole slide images (WSIs) to reveal that the HER2 scores determined by inspecting virtual IHC images are as accurate as their immunohistochemically stained counterparts. A second quantitative blinded study performed by the same diagnosticians further revealed that the virtually stained HER2 images exhibit a comparable staining quality in the level of nuclear detail, membrane clearness, and absence of staining artifacts with respect to their immunohistochemically stained counterparts. This virtual HER2 staining framework bypasses the costly, laborious, and time-consuming IHC staining procedures in laboratory and can be extended to other types of biomarkers to accelerate the IHC tissue staining used in life sciences and biomedical workflow. 

In an age where digitization is widespread in clinical and preclinical workflows, pathology is still predominantly practiced by microscopic evaluation of stained tissue specimens affixed on glass slides. Over the last decade, new high throughput digital scanning microscopes have ushered in the era of digital pathology that, along with recent advances in machine vision, have opened up new possibilities for Computer-Aided-Diagnoses. Despite these advances, the high infrastructural costs related to digital pathology and the perception that the digitization process is an additional and nondirectly reimbursable step have challenged its widespread adoption. Here, we discuss how emerging virtual staining technologies and machine learning can help to disrupt the standard histopathology workflow and create new avenues for the diagnostic paradigm that will benefit patients and healthcare systems alike via digital pathology. 

We present deep learning-based virtual immunohistochemical (IHC) HER2 staining of label-free breast tissue sections, matching the standard IHC HER2 staining performed by histotechnologists. 

Abstract Histological staining is a vital step in diagnosing various diseases and has been used for more than a century to provide contrast in tissue sections, rendering the tissue constituents visible for microscopic analysis by medical experts. However, this process is time consuming, labour intensive, expensive and destructive to the specimen. Recently, the ability to virtually stain unlabelled tissue sections, entirely avoiding the histochemical staining step, has been demonstrated using tissue-stain-specific deep neural networks. Here, we present a new deep-learning-based framework that generates virtually stained images using label-free tissue images, in which different stains are merged following a micro-structure map defined by the user. This approach uses a single deep neural network that receives two different sources of information as its input: (1) autofluorescence images of the label-free tissue sample and (2) a “digital staining matrix”, which represents the desired microscopic map of the different stains to be virtually generated in the same tissue section. This digital staining matrix is also used to virtually blend existing stains, digitally synthesizing new histological stains. We trained and blindly tested this virtual-staining network using unlabelled kidney tissue sections to generate micro-structured combinations of haematoxylin and eosin (H&E), Jones’ silver stain, and Masson’s trichrome stain. Using a single network, this approach multiplexes the virtual staining of label-free tissue images with multiple types of stains and paves the way for synthesizing new digital histological stains that can be created in the same tissue cross section, which is currently not feasible with standard histochemical staining methods.